Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
VioQuest Pharmaceuticals
Summary
Located in Monmouth, USA, VioQuest Pharmaceuticals is a research-based life sciences chemistry company dedicated to providing innovative asymmetric products and services to the pharmaceutical/biotechnology and fine chemical industries. VioQuest was founded in 2000. On February 18, 2003 VioQuest and Surg II completed the merger of the two companies. The combined company was named Chiral Quest and its common stock began trading on the OTC Bulletin Board under the symbol "CQST". On August, 12, 2004 company changes name form Chiral Quest to VioQuest. VioQuest aims to become a leading, high value technology provider and partner in the chiral therapeutics industry by offering proprietary catalysts, novel building blocks for discovery, and collaborative synthetic solutions.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Board of directors
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us